The DOI matches its Crossref record; 747 of the 747 references it cites were found in a registry or an index.
Lipids and Lipid Derivatives for RNA Delivery
Open accessAbstract
RNA-based therapeutics have shown great promise in treating a broad spectrum of diseases through various mechanisms including knockdown of pathological genes, expression of therapeutic proteins, and programmed gene editing. Due to the inherent instability and negative-charges of RNA molecules, RNA-based therapeutics can make the most use of delivery systems to overcome biological barriers and to release the RNA payload into the cytosol. Among different types of delivery systems, lipid-based RNA delivery systems, particularly lipid nanoparticles (LNPs), have been extensively studied due to their unique properties, such as simple chemical synthesis of lipid components, scalable manufacturing processes of LNPs, and wide packaging capability. LNPs represent the most widely used delivery systems for RNA-based therapeutics, as evidenced by the clinical approvals of three LNP-RNA formulations, patisiran, BNT162b2, and mRNA-1273. This review covers recent advances of lipids, lipid derivatives, and lipid-derived macromolecules used in RNA delivery over the past several decades. We focus mainly on their chemical structures, synthetic routes, characterization, formulation methods, and structure-activity relationships. We also briefly describe the current status of representative preclinical studies and clinical trials and highlight future opportunities and challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 747
Liang, F., Lindgren, G., Lin, A., Thompson, E. A., Ols, S., Röhss, J., John, S., Hassett, K., Yuzhakov, O., Bahl, K., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.006 · Cited by 395
Rehman, Z. U., Hoekstra, D., & Zuhorn, I. S. (2013) · ACS Nano · doi:10.1021/nn3049494 · Cited by 395
Materials for non-viral intracellular delivery of messenger RNA therapeutics
Kauffman, K. J., Webber, M. J., & Anderson, D. G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.032 · Cited by 395
Broderick, J. A., & Zamore, P. D. (2011) · Gene Therapy · doi:10.1038/gt.2011.50 · Cited by 388
Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
Fang, Y., Xue, J., Gao, S., Lu, A., Yang, D., Jiang, H., He, Y., & Shi, K. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1388451 · Cited by 386
Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery
Eygeris, Y., Patel, S., Jozic, A., & Sahay, G. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01386 · Cited by 379
Iwamoto, N., Butler, D. C. D., Svrzikapa, N., Mohapatra, S., Zlatev, I., Sah, D. W. Y., Meena, Standley, S. M., Lu, G., Apponi, L. H., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3948 · Cited by 377
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.026 · Cited by 376
Thiol–Yne Chemistry: A Powerful Tool for Creating Highly Functional Materials
Hoogenboom, R. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000401 · Cited by 374
Liu, J., Chang, J., Jiang, Y., Meng, X., Sun, T., Mao, L., Xu, Q., & Wang, M. (2019) · Advanced Materials · doi:10.1002/adma.201902575 · Cited by 373
Gene Therapy Progress and Prospects: Electroporation and other physical methods
Wells, D. J. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302337 · Cited by 372
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Gene delivery with synthetic (non viral) carriers
Brown, M. D., Schätzlein, A. G., & Uchegbu, I. F. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00861-4 · Cited by 367
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Sung, M. M. H., Tam, Y. K., & Cullis, P. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.059 · Cited by 366
Lee, J., Lee, K., Moon, S. H., Lee, Y., Park, T. G., & Cheon, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805998 · Cited by 365
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Zhuang, J., Gong, H., Zhou, J., Zhang, Q., Gao, W., Fang, R. H., & Zhang, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz6108 · Cited by 363
Laczkó, D., Hogan, M. J., Toulmin, S. A., Hicks, P., Lederer, K., Gaudette, B. T., Castaño, D., Amanat, F., Muramatsu, H., Oguin, T. H., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.019 · Cited by 363
MicroRNA therapeutics: Discovering novel targets and developing specific therapy
Bansal, P., Christopher, A., Kaur, R., Kaur, G., Kaur, A., & Gupta, V. (2016) · Perspectives in Clinical Research · doi:10.4103/2229-3485.179431 · Cited by 360
Kosuge, M., Takeuchi, T., Nakase, I., Jones, A. T., & Futaki, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700289w · Cited by 356
siRNA-based approaches in cancer therapy
Devi, G. R. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700931 · Cited by 353
Introduction to Lipids and Lipoproteins
Feingold, K. R., & Grünfeld, C. (2015) · MDText.com, Inc. eBooks · Cited by 353
Pardi, N., Secreto, A. J., Shan, X., Debonera, F., Glover, J., Yi, Y., Muramatsu, H., Ni, H., Mui, B. L., Tam, Y. K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14630 · Cited by 352
Advancement of the emerging field of RNA nanotechnology
Jasinski, D., Haque, F., Binzel, D. W., & Guo, P. (2017) · ACS Nano · doi:10.1021/acsnano.6b05737 · Cited by 352
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes
Dokka, S., Toledo, D., Shi, X., Castranova, V., & Rojanasakul, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1007504613351 · Cited by 349
Developments in liposomal drug delivery systems
Maurer, N., Fenske, D. B., & Cullis, P. R. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.6.923 · Cited by 344
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver
Miao, L., Lin, J., Huang, Y., Li, L., Delcassian, D., Ge, Y., Shi, Y., & Anderson, D. G. (2020) · Nature Communications · doi:10.1038/s41467-020-16248-y · Cited by 343
Francois, B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki862 · Cited by 343
Xu, X., Xie, K., Zhang, X.-Q., Pridgen, E. M., Park, G. Y., Cui, D. S., Shi, J., Wu, J., Kantoff, P. W., Lippard, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303958110 · Cited by 340
Intracellular delivery of nanomaterials: How to catch endosomal escape in the act
Martens, T. F., Remaut, K., Demeester, J., De Smedt, S. C., & Braeckmans, K. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.011 · Cited by 340
Eguchi, A., Meade, B. R., Chang, Y.-C., Fredrickson, C. T., Willert, K., Puri, N., & Dowdy, S. F. (2009) · Nature Biotechnology · doi:10.1038/nbt.1541 · Cited by 340
Islam, M. A., Xu, Y., Tao, W., Ubellacker, J. M., Lim, M., Aum, D., Lee, G. Y., Zhou, K., Zope, H., Yu, M., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0284-0 · Cited by 339
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
Brito, L. A., Chan, M., Shaw, C. A., Hekele, A., Carsillo, T., Schaefer, M., Archer, J., Seubert, A., Otten, G. R., Beard, C. W., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.133 · Cited by 338
High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
Kuai, R., Li, D., Chen, Y. E., Moon, J. J., & Schwendeman, A. (2016) · ACS Nano · doi:10.1021/acsnano.5b07522 · Cited by 338
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
Dahlman, J. E., Kauffman, K. J., Xing, Y., Shaw, T. E., Mir, F. F., Dlott, C. C., Langer, R., Anderson, D. G., & Wang, E. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620874114 · Cited by 335
Ball, R., Bajaj, P., & Whitehead, K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s123062 · Cited by 333
Arginine-Rich Molecular Transporters for Drug Delivery: Role of Backbone Spacing in Cellular Uptake
Rothbard, J. B., Kreider, E., VanDeusen, C. L., Wright, L., Wylie, B. L., & Wender, P. A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0105676 · Cited by 328
Otsuka, H., Uchimura, E., Koshino, H., Okano, T., & Kataoka, K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja021303r · Cited by 326
Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver
Akinc, A., Goldberg, M., Qin, J., Dorkin, J. R., Gamba-Vitalo, C., Maier, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Manoharan, M., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.36 · Cited by 323
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081683 · Cited by 321
Maeki, M., Kimura, N., Sato, Y., Harashima, H., & Tokeshi, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.008 · Cited by 319
Kong, N., Tao, W., Ling, X., Wang, J., Xiao, Y., Shi, S., Ji, X., Shajii, A., Gan, S. T., Kim, N. Y., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1565 · Cited by 314
Sago, C. D., Lokugamage, M. P., Paunovska, K., Vanover, D. A., Monaco, C. M., Shah, N. N., Gamboa Castro, M., Anderson, S. E., Rudoltz, T. G., Lando, G. N., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811276115 · Cited by 313
Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA
Ball, R. L., Hajj, K. A., Vizelman, J., Bajaj, P., & Whitehead, K. A. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01101 · Cited by 313
Circular RNA: a novel biomarker and therapeutic target for human cancers
Lei, B., Tian, Z., Fan, W., & Ni, B. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.28047 · Cited by 313
Hajj, K. A., Ball, R. L., Deluty, S. B., Singh, S. R., Strelkova, D., Knapp, C. M., & Whitehead, K. A. (2019) · Small · doi:10.1002/smll.201805097 · Cited by 312
Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of α-Tocopherol
Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., & Yokota, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.14 · Cited by 312
Synthetic materials at the forefront of gene delivery
Lostalé-Seijo, I., & Montenegro, J. (2018) · Nature Reviews Chemistry · doi:10.1038/s41570-018-0039-1 · Cited by 310
The many faces of the adamantyl group in drug design
Liu, J., Obando, D., Liao, V., Lifa, T., & Codd, R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.047 · Cited by 309
Sato, Y., Hatakeyama, H., Sakurai, Y., Hyodo, M., Akita, H., & Harashima, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.009 · Cited by 309
Li, J., Yang, Y., & Huang, L. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.020 · Cited by 306
Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery
Roy, I., Mitra, S., Maitra, A., & Mozumdar, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00452-0 · Cited by 303
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Ramaswamy, S., Tonnu, N., Tachikawa, K., Limphong, P., Vega, J. B., Karmali, P. P., Chivukula, P., & Verma, I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619653114 · Cited by 301
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Adachi, T., & Nakamura, Y. (2019) · Molecules · doi:10.3390/molecules24234229 · Cited by 300
Lipid Polymorphism:The Molecular Basis of Nonbilayer Phases
Gruner, S. M., Cullis, P. R., Hope, M. J., & Tilcock, C. P. S. (1985) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.14.060185.001235 · Cited by 296
Mannose-targeted systems for the delivery of therapeutics
Irache, J. M., Salman, H. H., Gamazo, C., & Espuelas, S. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.703 · Cited by 293
Aleku, M., Schulz, P., Keil, O., Santel, A., Schaeper, U., Dieckhoff, B., Janke, O., Endruschat, J., Durieux, B., Röder, N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2428 · Cited by 293
Scott, L. J., & Keam, S. J. (2021) · Drugs · doi:10.1007/s40265-020-01463-0 · Cited by 292
Influence of Cholesterol on the Association of Plasma Proteins with Liposomes
Semple, S. C., Chonn, A., & Cullis, P. R. (1996) · Biochemistry · doi:10.1021/bi950414i · Cited by 291
Hou, X., Zhang, X., Zhao, W., Zeng, C., Deng, B., McComb, D. W., Du, S., Zhang, C., Li, W., & Dong, Y. (2020) · Nature Nanotechnology · doi:10.1038/s41565-019-0600-1 · Cited by 290
Self-citationMcKinlay, C. J., Vargas, J. R., Blake, T. R., Hardy, J. W., Kanada, M., Contag, C. H., Wender, P. A., & Waymouth, R. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614193114 · Cited by 288
Fenton, O. S., Kauffman, K. J., Kaczmarek, J. C., McClellan, R. L., Jhunjhunwala, S., Tibbitt, M. W., Zeng, M. D., Appel, E. A., Dorkin, J. R., Mir, F. F., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606944 · Cited by 288
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
Stamatatos, L., Leventis, R., Zuckermann, M. J., & Silvius, J. R. (1988) · Biochemistry · doi:10.1021/bi00411a005 · Cited by 286
Antisense oligonucleotides in therapy for neurodegenerative disorders
Evers, M. M., Toonen, L. J. A., & van Roon-Mom, W. M. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.008 · Cited by 286
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Selby, L. I., Cortez‐Jugo, C. M., Such, G. K., & Johnston, A. P. R. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 283
Thewalt, J. L., & Bloom, M. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81681-8 · Cited by 279
COVID-19: A review of therapeutic strategies and vaccine candidates
Izda, V., Jeffries, M. A., & Sawalha, A. H. (2021) · Clinical Immunology · doi:10.1016/j.clim.2020.108634 · Cited by 274
The Headgroup Evolution of Cationic Lipids for Gene Delivery
Zhi, D., Zhang, S., Cui, S., Zhao, Y., Wang, Y., & Zhao, D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300381s · Cited by 271
Laser-Activated Gene Silencing via Gold Nanoshell−siRNA Conjugates
Braun, G. B., Pallaoro, A., Wu, G., Missirlis, D., Zasadzinski, J. A., Tirrell, M., & Reich, N. O. (2009) · ACS Nano · doi:10.1021/nn900469q · Cited by 270
Hydrolytic Degradation of Poly(ethylene oxide)-block-Polycaprolactone Worm Micelles
Geng, Y., & Discher, D. E. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053902e · Cited by 269
Wang, T., Upponi, J. R., & Torchilin, V. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.013 · Cited by 268
Zuhorn, I. S., Bakowsky, U., Polushkin, E., Visser, W. H., Stuart, M. C. A., Engberts, J. B. F. N., & Hoekstra, D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.018 · Cited by 268
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Richner, J. M., Jagger, B. W., Shan, C., Fontes, C. R., Dowd, K. A., Cao, B., Himansu, S., Caine, E. A., Nunes, B. T. D., Medeiros, D. B. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.040 · Cited by 267
Roles of lipid polymorphism in intracellular delivery
Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 266
Olton, D., Li, J., Wilson, M. E., Rogers, T., Close, J., Huang, L., Kumta, P. N., & Sfeir, C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.10.026 · Cited by 264
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
Li, B., Luo, X., Deng, B., Wang, J., McComb, D. W., Shi, Y., Gaensler, K. M. L., Tan, X., Dunn, A. L., Kerlin, B. A., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03528 · Cited by 261
Self-citationA Review on Electroporation-Based Intracellular Delivery
Shi, J., Ma, Y., Zhu, J., Chen, Y., Sun, Y., Yao, Y., Yang, Z., & Xie, J. (2018) · Molecules · doi:10.3390/molecules23113044 · Cited by 261
Schultheis, B., Strumberg, D., Santel, A., Vank, C., Gebhardt, F., Keil, O., Lange, C., Giese, K., Kaufmann, J., Khan, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0376 · Cited by 260
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
Patel, S., Ryals, R. C., Weller, K. K., Pennesi, M. E., & Sahay, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.015 · Cited by 260
Cationic liposomes as vaccine adjuvants
Christensen, D., Korsholm, K. S., Andersen, P., & Agger, E. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.17 · Cited by 259
Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics
Koopmanschap, G., Ruijter, E., & Orru, R. V. (2014) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.10.50 · Cited by 256
Zhang, R., El-Mayta, R., Murdoch, T. J., Warzecha, C. C., Billingsley, M. M., Shepherd, S. J., Gong, N., Wang, L., Wilson, J. M., Lee, D., et al. (2021) · Biomaterials Science · doi:10.1039/d0bm01609h · Cited by 255
Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery
Nogueira, S. S., Schlegel, A., Maxeiner, K., Weber, B., Barz, M., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Ramishetti, S., Peer, D., et al. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01834 · Cited by 252
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery
Fenton, O. S., Kauffman, K. J., McClellan, R. L., Appel, E. A., Dorkin, J. R., Tibbitt, M. W., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2016) · Advanced Materials · doi:10.1002/adma.201505822 · Cited by 252
Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth
Michael, J. V., Wurtzel, J. G. T., Mao, G. F., Rao, A. K., Kolpakov, M. A., Sabri, A., Hoffman, N. E., Rajan, S., Tomar, D., Madesh, M., et al. (2017) · Blood · doi:10.1182/blood-2016-11-751099 · Cited by 252
Scheule, R. K., George, J. A. S., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., Wang, K. X., Lee, E. R., Harris, D. J., Jiang, C., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-689 · Cited by 251
Kim, W. J., Christensen, L. V., Jo, S., Yockman, J. W., Jeong, J. H., Kim, Y.-H., & Kim, S. W. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.022 · Cited by 251
Wang, M., Alberti, K., Sun, S., Arellano, C. L., & Xu, Q. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311245 · Cited by 251
Transfection Efficiency of Cationic Lipids with Different Hydrophobic Domains in Gene Delivery
Zhi, D., Zhang, S., Wang, B., Zhao, Y., Yang, B., & Yu, S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900393r · Cited by 244
Stable RNA nanoparticles as potential new generation drugs for cancer therapy
Shu, Y., Pi, F., Sharma, A., Rajabi, M., Haque, F., Shu, D., Leggas, M., Evers, B. M., & Guo, P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.006 · Cited by 244
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications
Dave, V., Tak, K., Sohgaura, A., Gupta, A., Sadhu, V., & Reddy, K. R. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.03.017 · Cited by 241
Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic Liposomes
Lappalainen, K., Jääskeläinen, I., Syrjänen, K., Urtti, A., & Syrjänen, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018932714745 · Cited by 238
N-(Triisopropylsilyl)pyrrole. A progenitor "par excellence" of 3-substituted pyrroles
Bray, B. L., Mathies, P. H., Naef, R., Solas, D. R., Tidwell, T. T., Artis, D. R., & Muchowski, J. M. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00313a019 · Cited by 238
Tousignant, J. D., Gates, A. L., Ingram, L. A., Johnson, C. L., Nietupski, J. B., Cheng, S. H., Eastman, S. J., & Scheule, R. K. (2000) · Human Gene Therapy · doi:10.1089/10430340050207984 · Cited by 236
Drug Targeting via Platelet Membrane–Coated Nanoparticles
Wang, S., Duan, Y., Zhang, Q., Komarla, A., Gong, H., Gao, W., & Zhang, L. (2020) · Small Structures · doi:10.1002/sstr.202000018 · Cited by 233
Maurer, N., Wong, K. F., Stark, H., Louie, L., McIntosh, D., Wong, T., Scherrer, P., Semple, S. C., & Cullis, P. R. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76202-9 · Cited by 232
Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications
Benizri, S., Gissot, A., Martin, A., Vialet, B., Grinstaff, M. W., & Barthélémy, P. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00761 · Cited by 231
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
Han, X., Liu, Z., Jo, M. C., Zhang, K., Li, Y., Zeng, Z., Li, N., Zu, Y., & Qin, L. (2015) · Science Advances · doi:10.1126/sciadv.1500454 · Cited by 230
Advances in lipid nanoparticles for siRNA delivery
Tam, Y., Chen, S., & Cullis, P. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030498 · Cited by 229
John, S., Yuzhakov, O., Woods, A., Deterling, J., Hassett, K., Shaw, C. A., & Ciaramella, G. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.029 · Cited by 229
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
Forterre, A., Komuro, H., Aminova, S., & Harada, M. (2020) · Cancers · doi:10.3390/cancers12071852 · Cited by 227
Suzuki, T., Suzuki, Y., Hihara, T., Kubara, K., Kondo, K., Hyodo, K., Yamazaki, K., Ishida, T., & Ishihara, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119792 · Cited by 225
Bettinger, T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.18.3882 · Cited by 224
Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy
Mainini, F., & Eccles, M. R. (2020) · Molecules · doi:10.3390/molecules25112692 · Cited by 224
Characterizing Extracellular Vesicles and Their Diverse RNA Contents
Veziroglu, E. M., & Mias, G. I. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00700 · Cited by 222
Cheng, Q., Wei, T., Jia, Y., Farbiak, L., Zhou, K., Zhang, S., Wei, Y., Zhu, H., & Siegwart, D. J. (2018) · Advanced Materials · doi:10.1002/adma.201805308 · Cited by 221
Cationic lipids activate intracellular signaling pathways
Lonez, C., Vandenbranden, M., & Ruysschaert, J.-M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.05.009 · Cited by 221
Matsuda, S., Keiser, K., Nair, J. K., Charisse, K., Manoharan, R. M., Kretschmer, P., Peng, C. G., V. Kel’in, A., Kandasamy, P., Willoughby, J. L. S., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb501028c · Cited by 221
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
Mahmoodi Chalbatani, G., Dana, H., Gharagouzloo, E., Grijalvo, S., Eritja, R., Logsdon, C. D., Memari, F., Miri, S. R., Rezvani Rad, M., & Marmari, V. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200253 · Cited by 221
A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery
Lu, J. J., Langer, R., & Chen, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900023v · Cited by 219
Ma, F., Yang, L., Sun, Z., Chen, J., Rui, X., Glass, Z., & Xu, Q. (2020) · Science Advances · doi:10.1126/sciadv.abb4429 · Cited by 218
Perche, F., Benvegnu, T., Berchel, M., Lebegue, L., Pichon, C., Jaffrès, P.-A., & Midoux, P. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.12.010 · Cited by 218
Transfection Mediated by Gemini Surfactants: Engineered Escape from the Endosomal Compartment
Bell, P. C., Bergsma, M., Dolbnya, I. P., Bras, W., Stuart, M. C. A., Rowan, A. E., Feiters, M. C., & Engberts, J. B. F. N. (2003) · Journal of the American Chemical Society · doi:10.1021/ja020707g · Cited by 217
Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation
Yang, Z., Xie, J., Zhu, J., Kang, C., Chiang, C., Wang, X., Wang, X., Kuang, T., Chen, F., Chen, Z., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.008 · Cited by 217
Chen, Y., Bathula, S. R., Li, J., & Huang, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125906 · Cited by 216
Islam, M. A., Rice, J., Reesor, E., Zope, H., Tao, W., Lim, M., Ding, J., Chen, Y., Aduluso, D., Zetter, B. R., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120431 · Cited by 216
Ding, X., Stewart, M. P., Sharei, A., Weaver, J. C., Langer, R. S., & Jensen, K. F. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0039 · Cited by 213
Zhang, X., Goel, V., & Robbie, G. J. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1553 · Cited by 213
Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes
DIMITRIADIS, G. J. (1978) · Nature · doi:10.1038/274923a0 · Cited by 212
“Smart” delivery of antisense oligonucleotides by anionic pH-sensitive liposomes
Fattal, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.037 · Cited by 211
A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
Ramishetti, S., Hazan‐Halevy, I., Palakuri, R., Chatterjee, S., Naidu Gonna, S., Dammes, N., Freilich, I., Kolik Shmuel, L., Danino, D., & Peer, D. (2020) · Advanced Materials · doi:10.1002/adma.201906128 · Cited by 211
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.208 · Cited by 209
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery
van der Woude, I., Wagenaar, A., Meekel, A. A. P., ter Beest, M. B. A., Ruiters, M. H. J., Engberts, J. B. F. N., & Hoekstra, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1160 · Cited by 209
Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes
Shi, J., Kundrat, L., Pishesha, N., Bilate, A., Theile, C., Maruyama, T., Dougan, S. K., Ploegh, H. L., & Lodish, H. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409861111 · Cited by 209
Huang, J.-L., Jiang, G., Song, Q.-X., Gu, X., Hu, M., Wang, X.-L., Song, H.-H., Chen, L.-P., Lin, Y.-Y., Jiang, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms15144 · Cited by 209
Exploiting cell surface thiols to enhance cellular uptake
Torres, A. G., & Gait, M. J. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.12.002 · Cited by 208
Lipid-based mRNA vaccine delivery systems
Midoux, P., & Pichon, C. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.986104 · Cited by 207
Gujrati, M., Malamas, A., Shin, T., Jin, E., Sun, Y., & Lu, Z.-R. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400787s · Cited by 206
Paunovska, K., Da Silva Sanchez, A. J., Sago, C. D., Gan, Z., Lokugamage, M. P., Islam, F. Z., Kalathoor, S., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201807748 · Cited by 205
Matsumoto, A., Sato, N., Kataoka, K., & Miyahara, Y. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902964m · Cited by 205
Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy
Erel-Akbaba, G., Carvalho, L. A., Tian, T., Zinter, M., Akbaba, H., Obeid, P. J., Chiocca, E. A., Weissleder, R., Kantarci, A. G., & Tannous, B. A. (2019) · ACS Nano · doi:10.1021/acsnano.8b08177 · Cited by 202
Lipid-Based Nanocarriers for RNA Delivery
Xue, H., Guo, P., Wen, W.-C., & Wong, H. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150531164540 · Cited by 201
Polymers in Small-Interfering RNA Delivery
Singha, K., Namgung, R., & Kim, W. J. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0293 · Cited by 198
Wahane, A., Waghmode, A., Kapphahn, A., Dhuri, K., Gupta, A., & Bahal, R. (2020) · Molecules · doi:10.3390/molecules25122866 · Cited by 197
Leal, C., Bouxsein, N. F., Ewert, K. K., & Safinya, C. R. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1059763 · Cited by 195
Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity
ZHANG, J., LIU, F., & HUANG, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.004 · Cited by 195
The effects of PEGylation on LNP based mRNA delivery to the eye
Ryals, R. C., Patel, S., Acosta, C., McKinney, M., Pennesi, M. E., & Sahay, G. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241006 · Cited by 194
Maeki, M., Fujishima, Y., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187962 · Cited by 194
Lipid nanoparticle delivery systems for siRNA-based therapeutics
Wan, C., Allen, T. M., & Cullis, P. R. (2014) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0161-z · Cited by 193
Shi, G., Guo, W., Stephenson, S. M., & Lee, R. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00017-2 · Cited by 192
de Alwis, R., Gan, E. S., Chen, S., Leong, Y. S., Tan, H. C., Zhang, S. L., Yau, C., Low, J. G. H., Kalimuddin, S., Matsuda, D., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.001 · Cited by 191
Akhtar, M. J., Ahamed, M., Kumar, S., Siddiqui, H., Patil, G., Ashquin, M., & Ahmad, I. (2010) · Toxicology · doi:10.1016/j.tox.2010.07.010 · Cited by 191
In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
Audouy, S. A. L., de Leij, L. F. M. H., Hoekstra, D., & Molema, G. (2002) · Pharmaceutical Research · doi:10.1023/a:1020989709019 · Cited by 189
A Novel Series of Amphiphilic Imidazolinium Compounds for in Vitro and in Vivo Gene Delivery
Solodin, I., Brown, C. S., Bruno, M. S., Chow, C.-Y., Jang, E.-H., Debs, R. J., & Heath, T. D. (1995) · Biochemistry · doi:10.1021/bi00041a033 · Cited by 189
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery
Alabi, C. A., Love, K. T., Sahay, G., Yin, H., Luly, K. M., Langer, R., & Anderson, D. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306529110 · Cited by 188
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
Ämmälä, C., Drury, W. J., Knerr, L., Ahlstedt, I., Stillemark-Billton, P., Wennberg-Huldt, C., Andersson, E.-M., Valeur, E., Jansson-Löfmark, R., Janzén, D., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat3386 · Cited by 188
Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination
Persano, S., Guevara, M. L., Li, Z., Mai, J., Ferrari, M., Pompa, P. P., & Shen, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.019 · Cited by 187
How cationic lipids transfer nucleic acids into cells and across cellular membranes: Recent advances
Rehman, Z. U., Zuhorn, I. S., & Hoekstra, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.014 · Cited by 186
Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo
DiTommaso, T., Cole, J. M., Cassereau, L., Buggé, J. A., Hanson, J. L. S., Bridgen, D. T., Stokes, B. D., Loughhead, S. M., Beutel, B. A., Gilbert, J. B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809671115 · Cited by 185
Assessment of Tumor Metastasis by the Direct Determination of Cell‐Membrane Sialic Acid Expression
Matsumoto, A., Cabral, H., Sato, N., Kataoka, K., & Miyahara, Y. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201001220 · Cited by 183
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Durieux, B., Löffler, K., Fechtner, M., Röhl, T., Fisch, G., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302778 · Cited by 183
Zhou, K., Nguyen, L. H., Miller, J. B., Yan, Y., Kos, P., Xiong, H., Li, L., Hao, J., Minnig, J. T., Zhu, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520756113 · Cited by 183
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Zhang, X., Zhao, W., Nguyen, G. N., Zhang, C., Zeng, C., Yan, J., Du, S., Hou, X., Li, W., Jiang, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc2315 · Cited by 182
Self-citationBasha, G., Novobrantseva, T. I., Rosin, N., Tam, Y. Y. C., Hafez, I. M., Wong, M. K., Sugo, T., Ruda, V. M., Qin, J., Klebanov, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.190 · Cited by 181
Bogers, W. M., Oostermeijer, H., Mooij, P., Koopman, G., Verschoor, E. J., Davis, D., Ulmer, J. B., Brito, L. A., Cu, Y., Banerjee, K., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu522 · Cited by 181
Sato, Y., Hashiba, K., Sasaki, K., Maeki, M., Tokeshi, M., & Harashima, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.001 · Cited by 179
Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes
Zhao, X., Chen, J., Qiu, M., Li, Y., Glass, Z., & Xu, Q. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008082 · Cited by 179
Nuclease Resistance and Antisense Activity of Modified Oligonucleotides Targeted to Ha-
Monia, B. P., Johnston, J. F., Sasmor, H., & Cummins, L. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14533 · Cited by 176
Journey of siRNA: Clinical Developments and Targeted Delivery
Nikam, R. R., & Gore, K. R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0715 · Cited by 176
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Hsu, S.-H., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 173
Focusing on clathrin-mediated endocytosis.
Rappoport, J. Z. (2008) · Biochemical Journal · doi:10.1042/bj20080474 · Cited by 172
Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma
Liang, Y., Xiao, H., Xu, M., Ye, X.-Z., Hu, J., Li, F., Li, M., Luo, C., Yu, S., Bian, X., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.011 · Cited by 172
Novel vaccine technologies for the 21st century
Mascola, J. R., & Fauci, A. S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0243-3 · Cited by 171
2-Deoxystreptamine: Central Scaffold of Aminoglycoside Antibiotics
Busscher, G. F., Rutjes, F. P. J. T., & van Delft, F. L. (2005) · Chemical Reviews · doi:10.1021/cr0404085 · Cited by 169
Stockert, R. J., Morell, A. G., & Scheinberg, I. H. (1974) · Science · doi:10.1126/science.186.4161.365 · Cited by 169
Vaidya, A. M., Sun, Z., Ayat, N., Schilb, A., Liu, X., Jiang, H., Sun, D., Scheidt, J., Qian, V., He, S., et al. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00028 · Cited by 169
RNA Nanotechnology-Mediated Cancer Immunotherapy
Lin, Y.-X., Wang, Y., Blake, S., Yu, M., Mei, L., Wang, H., & Shi, J. (2020) · Theranostics · doi:10.7150/thno.35568 · Cited by 169
Designer lipids for drug delivery: From heads to tails
Kohli, A. G., Kierstead, P. H., Venditto, V. J., Walsh, C. L., & Szoka, F. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.047 · Cited by 167
Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery
Herrera, M., Kim, J., Eygeris, Y., Jozic, A., & Sahay, G. (2021) · Biomaterials Science · doi:10.1039/d0bm01947j · Cited by 167
Tunable pH-Sensitive Liposomes Composed of Mixtures of Cationic and Anionic Lipids
Hafez, I. M., Ansell, S., & Cullis, P. R. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76395-8 · Cited by 166
Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain
Rungta, R. L., Choi, H. B., Lin, P. J., Ko, R. W., Ashby, D., Nair, J., Manoharan, M., Cullis, P. R., & MacVicar, B. A. (2013) · Molecular Therapy—Nucleic Acids · doi:10.1038/mtna.2013.65 · Cited by 165
Microinjection as a tool of mechanical delivery
Zhang, Y., & Yu, L.-C. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.07.005 · Cited by 164
Self-citationA novel cationic niosome formulation for gene delivery to the retina
Puras, G., Mashal, M., Zárate, J., Agirre, M., Ojeda, E., Grijalvo, S., Eritja, R., Diaz-Tahoces, A., Martínez Navarrete, G., Avilés-Trigueros, M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.004 · Cited by 164
Addressing the problem of cationic lipid-mediated toxicity: The magnetoliposome model
Soenen, S. J. H., Brisson, A. R., & De Cuyper, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.040 · Cited by 162
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab’ fragments
Béduneau, A., Saulnier, P., Hindré, F., Clavreul, A., Leroux, J.-C., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.014 · Cited by 161
Paunovska, K., Gil, C. J., Lokugamage, M. P., Sago, C. D., Sato, M., Lando, G. N., Gamboa Castro, M., Bryksin, A. V., & Dahlman, J. E. (2018) · ACS Nano · doi:10.1021/acsnano.8b03640 · Cited by 160
Boiziau, C., Kurfürst, R., Cazenave, C., Roig, V., Thuong, N. T., & Toulmé, J. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.5.1113 · Cited by 160
Desigaux, L., Sainlos, M., Lambert, O., Chèvre, R., Letrou-Bonneval, E., Vigneron, J., Lehn, P., Lehn, J., & Pitard, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707431104 · Cited by 160
Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses
Zhang, D., Lee, H., Wang, X., Rai, A., Groot, M., & Jin, Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.007 · Cited by 160
Nucleic‐Acid Structures as Intracellular Probes for Live Cells
Samanta, D., Ebrahimi, S. B., & Mirkin, C. A. (2019) · Advanced Materials · doi:10.1002/adma.201901743 · Cited by 160
Parvani, J. G., Gujrati, M. D., Mack, M. A., Schiemann, W. P., & Lu, Z.-R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3485 · Cited by 159
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., Kauffman, K. J., Zhang, J., Yahalom, B., Anderson, D. G., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.46 · Cited by 159
Wijagkanalan, W., Kawakami, S., Takenaga, M., Igarashi, R., Yamashita, F., & Hashida, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.011 · Cited by 158
Zhang, Y., Li, H., Sun, J., Gao, J., Liu, W., Li, B., Guo, Y., & Chen, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.035 · Cited by 158
Self-citationAdamantane in Drug Delivery Systems and Surface Recognition
Štimac, A., Šekutor, M., Mlinarić-Majerski, K., Frkanec, L., & Frkanec, R. (2017) · Molecules · doi:10.3390/molecules22020297 · Cited by 158
Alnylam launches era of RNAi drugs
Garber, K. (2018) · Nature Biotechnology · doi:10.1038/nbt0918-777 · Cited by 157
Diversity of PEGylation methods of liposomes and their influence on RNA delivery
Nosova, A. S., Koloskova, O. O., Nikonova, A. A., Simonova, V. A., Vv, S., Kudlay, D. A., & Khaitov, M. R. (2019) · MedChemComm · doi:10.1039/c8md00515j · Cited by 157
Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
Lokugamage, M. P., Sago, C. D., Gan, Z., Krupczak, B. R., & Dahlman, J. E. (2019) · Advanced Materials · doi:10.1002/adma.201902251 · Cited by 157
Formulation and Delivery of siRNA by Oleic Acid and Stearic Acid Modified Polyethylenimine
Alshamsan, A., Haddadi, A., Incani, V., Samuel, J., Lavasanifar, A., & Uludağ, H. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000815 · Cited by 156
Heyes, J. A., Niculescu‐Duvaz, D., Cooper, R. G., & Springer, C. J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010918g · Cited by 156
Ewert, K. K., Zidovska, A., Ahmad, A. K., Bouxsein, N. F., Evans, H. M., McAllister, C. S., Samuel, C. E., & Safinya, C. R. (2010) · Topics in current chemistry · doi:10.1007/128_2010_70 · Cited by 155
A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo
Hajj, K. A., Melamed, J. R., Chaudhary, N., Lamson, N. G., Ball, R. L., Yerneni, S. S., & Whitehead, K. A. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00596 · Cited by 155
Brazzoli, M., Magini, D., Bonci, A., Buccato, S., Giovani, C., Kratzer, R., Zurli, V., Mangiavacchi, S., Casini, D., Brito, L. M., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01786-15 · Cited by 154
Zhupanyn, P., Ewe, A., Büch, T., Malek, A. V., Rademacher, P., Müller, C., Reinert, A., Jaimes, Y., & Aigner, A. M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.032 · Cited by 153
Wang, J., Megha, M., & London, E. (2004) · Biochemistry · doi:10.1021/bi035696y · Cited by 152
Chien, P.-Y., Wang, J., Carbonaro, D., Lei, S., Miller, B., Sheikh, S., Ali, S. M., Ahmad, M. U., & Ahmad, I. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700793 · Cited by 152
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
Zeng, C., Hou, X., Yan, J., Zhang, C., Li, W., Zhao, W., Du, S., & Dong, Y. (2020) · Advanced Materials · doi:10.1002/adma.202004452 · Cited by 152
Self-citationA novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
Tai, W., Zhang, X., Drelich, A., Shi, J., Hsu, J. C., Luchsinger, L., Hillyer, C. D., Tseng, C.-T. K., Jiang, S., & Du, L. (2020) · Cell Research · doi:10.1038/s41422-020-0387-5 · Cited by 151
Zuidam, N. J., & Barenholz, Y. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00110-7 · Cited by 151
Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
Li, S., Chono, S., & Huang, L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.002 · Cited by 151
Cited by
Drug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Chemistry of Lipid Nanoparticles for RNA Delivery
Eygeris, Y., Gupta, M., Kim, J., & Sahay, G. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00544 · Cited by 873
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
Liu, R., Luo, C., Pang, Z., Zhang, J., Ruan, S., Wu, M., Wang, L., Sun, T., Li, N., Han, L., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.05.032 · Cited by 516
Metadata
- Authors
- Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-07-19
- Volume
- 121
- Issue
- 20
- Pages
- 12181-12277
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W3184644021
- Cited by
- 626
- References
- 747
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.